Precision Nanosystems NanoAssemblr Benchtop for rapid manufacture of nanoparticles

Saturday, 01 June, 2019 | Supplied by: ATA Scientific Pty Ltd

Precision Nanosystems NanoAssemblr Benchtop for rapid manufacture of nanoparticles

Current nanoparticle manufacturing methods can be sensitive to reaction conditions, difficult to reproduce, labour intensive and challenging to scale. The automated NanoAssemblr Benchtop is designed to solve these significant issues and allow scientists to accelerate the discovery and development of novel nanomedicines from bench to clinic.

The NanoAssemblr technology is designed for fast and controlled molecular self-assembly of nanoparticles (~20 to 120+ nm) at nanolitre scale (<20 nL) through the use of highly engineered microfluidic mixing cartridges. Formulation runs require less than a minute therefore more than 30 formulations can be completed in a day for rapid optimisation. Fast mixing (<3 ms) on a small scale allows reproducible control over particle formation, resulting in consistent particle populations with low polydispersities.

Nanoparticles can be engineered with defined characteristics including chemical composition, drug/component ratio and drug/component concentrations. Small molecules, peptides and nucleic acids can be formulated into lipid, polymer or hybrid nanoparticles and more.

Applications include: protein delivery and screening, nucleic acid delivery and screening, nanoparticle design, targeted drug delivery, lipid nanoparticles, liposomes and polymeric nanoparticles.

For more information: https://www.atascientific.com.au/products/nanoassemblr-benchtop/.

Online: www.atascientific.com.au
Phone: 02 9541 3500
Related Products

Parse Biosciences Evercode BCR kits for mouse samples

The kits enable researchers to profile the mouse BCR repertoire alongside whole transcriptome...

OGT SureSeq CLL + CNV V3 Panel

The updated NGS panel offers users more comprehensive variant detection to improve confidence in...

Beckman Coulter Life Sciences Cydem VT Automated Clone Screening System

The system is designed to reduce time to market for biologic drug discovery and monoclonal...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd